DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Campath (Alemtuzumab) - C-Reactive Protein Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with C-Reactive Protein Increased (12)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include c-reactive protein increased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Campath side effects in female

Reported by a physician from Germany on 2012-04-16

Patient: female, weighing 69.7 kg (153.3 pounds)

Reactions: Cardiac Failure, C-Reactive Protein Increased, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-29

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-23

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2012-01-09
    End date: 2012-02-20

Other drugs received by patient: Ciprofloxacin; Cotrim Forte EU RHO; Acyclovir; Levothyroxine Sodium; Ramipril Plus



Possible Campath side effects in female

Reported by a physician from Germany on 2012-03-20

Patient: female, weighing 69.7 kg (153.3 pounds)

Reactions: C-Reactive Protein Increased, Cardiac Failure, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-29

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-23

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2012-01-09
    End date: 2012-02-20

Other drugs received by patient: Levothyroxine Sodium; Acyclovir; Ramipril Plus; Cotrim Forte EU RHO; Ciprofloxacin



Possible Campath side effects in female

Reported by a physician from Germany on 2012-03-12

Patient: female, weighing 160.0 kg (352.0 pounds)

Reactions: C-Reactive Protein Increased, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-01-29

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-23

Neulasta
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2012-02-09
    End date: 2012-02-20

Other drugs received by patient: Ciprofloxacin; Cotrim Forte EU RHO; Acyclovir; Ramipril Plus; Levothyroxine Sodium



Possible Campath side effects in female

Reported by a physician from Germany on 2012-03-08

Patient: female, weighing 160.0 kg (352.0 pounds)

Reactions: C-Reactive Protein Increased, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-01-29

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-23

Neulasta
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2012-02-09
    End date: 2012-02-20

Other drugs received by patient: Ciprofloxacin; Levothyroxine Sodium; Cotrim Forte EU RHO; Acyclovir; Ramipril Plus



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-21

Patient: male, weighing 69.2 kg (152.2 pounds)

Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    End date: 2011-10-07

Campath
    Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-07-24

Dexamethasone
    Dosage: 40 mg, qd 1-4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27

Dexamethasone
    Dosage: 40 mg, qd 15-18
    Administration route: Oral
    End date: 2011-10-03

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acetaminophen; Valaciclovir; Clemastine Fumarate



Possible Campath side effects in female

Reported by a physician from Germany on 2011-12-15

Patient: female, weighing 71.0 kg (156.2 pounds)

Reactions: C-Reactive Protein Increased, General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 unk, unk
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-16

Dexamethasone
    Dosage: 40 unk, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-10

Pegfilgrastim
    Dosage: 6 unk, unk
    Indication: Neutropenia
    Start date: 2011-11-07
    End date: 2011-11-07

Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acyclovir; Levofloxacin; Acetylcysteine



Possible Campath side effects in male

Reported by a physician from Germany on 2011-11-30

Patient: male, weighing 69.2 kg (152.2 pounds)

Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    End date: 2011-10-07

Campath
    Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-07-24

Dexamethasone
    Dosage: 40 mg, qd 1-4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27

Dexamethasone
    Dosage: 40 mg, qd 15-18
    Administration route: Oral
    End date: 2011-10-03

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Cotrim; Valaciclovir; Paracetamol



Possible Campath side effects in female

Reported by a physician from Germany on 2011-11-28

Patient: female, weighing 71.0 kg (156.2 pounds)

Reactions: C-Reactive Protein Increased, General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 unk, unk
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-16

Dexamethasone
    Dosage: 40 unk, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-10

Pegfilgrastim
    Dosage: 6 unk, unk
    Indication: Neutropenia
    Start date: 2011-11-07
    End date: 2011-11-07

Other drugs received by patient: Levofloxacin; Acetylcysteine; Acyclovir; Cotrim; Pantoprazole Sodium



Possible Campath side effects in male

Reported by a physician from Germany on 2011-11-16

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: C-Reactive Protein Increased, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-07

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-06

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Acetaminophen; Cotrim; Valaciclovir



Possible Campath side effects in male

Reported by a physician from Germany on 2011-11-02

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: C-Reactive Protein Increased, Pneumonia Bacterial, Chills, Febrile Neutropenia, Troponin Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd on days 1, 3 and 5
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-21
    End date: 2011-08-12

Campath
    Dosage: 30 mg, qd on days 1, 3 and 5
    Start date: 2011-08-29
    End date: 2011-09-12

Dexamethasone
    Dosage: 40 mg, qdx4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-09-02
    End date: 2011-09-05

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-09-02

Other drugs received by patient: Candesartan Cilexetil; Simvastatin; Nebivolol HCL; Marcumar; Pantoprazole; Novalgin; Pentacarinat; Tamsulosin HCL



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-27

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: C-Reactive Protein Increased, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-07

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-06

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Pantoprazole Sodium; Valaciclovir; Clemastine Fumarate; Cotrim; Acetaminophen



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-26

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia Bacterial, C-Reactive Protein Increased, Chills, Febrile Neutropenia, Troponin Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-21
    End date: 2011-08-12

Dexamethasone
    Dosage: 40 mg, qdx4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-09-02
    End date: 2011-09-05

Narcumar
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-09-02

Other drugs received by patient: Novalgin; Pantoprazole; Tamsulosin HCL; Pentacarinat; Nebivolol HCL; Simvastin-Mepha

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017